Decreased RGS6 expression is associated with poor prognosis in pancreatic cancer patients

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 4120-4127

  Jiang, Nan ^a   Xue, Ruihua ^a   Bu, Fangfang ^a   Tong, Xin ^a   Qiang, Jiankun ^a   Liu, Rong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Clinical pathology; Pancreatic neoplasms; Prognosis; RGS protein

Indexed keywords

RGS PROTEIN; RGS6 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; AGED; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

ADENOCARCINOMA; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RGS PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84906272887     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dohlman HG, Apaniesk D, Chen Y, Song J and Nusskern D. Inhibition of G-protein signaling by dominant gain-of-function mutations in Sst2p, a pheromone desensitization factor in Saccharomyces cerevisiae. Mol Cell Biol 1995; 15: 3635-3643.
2. Berman DM and Gilman AG. Mammalian RGS proteins: barbarians at the gate. J Biol Chem 1998; 273: 1269-1272.
3. Dohlman HG and Thorner J. RGS proteins and signaling by heterotrimeric G proteins. J Biol Chem 1997; 272: 3871-3874.
4. Berman DM, Kozasa T and Gilman AG. The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J Biol Chem 1996; 271: 27209-27212.
5. Ross EM and Wilkie TM. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 2000; 69: 795-827.
6. Hepler JR, Berman DM, Gilman AG and Kozasa T. RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha. Proc Natl Acad Sci U S A 1997; 94: 428-432.
7. De Vries L, Zheng B, Fischer T, Elenko E and Farquhar MG. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 2000; 40: 235-271.
8. Siderovski DP and Willard FS. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int J Biol Sci 2005; 1: 51-66.
9. Wieland T and Mittmann C. Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol Ther 2003; 97: 95-115.
10. Cabrera JL, de Freitas F, Satpaev DK and Slepak VZ. Identification of the Gbeta5-RGS7 protein complex in the retina. Biochem Biophys Res Commun 1998; 249: 898-902.
11. Anderson GR, Posokhova E and Martemyanov KA. The R7 RGS protein family: multi-subunit regulators of neuronal G protein signaling. Cell Biochem Biophys 2009; 54: 33-46.
12. Snow BE, Krumins AM, Brothers GM, Lee SF, Wall MA, Chung S, Mangion J, Arya S, Gilman AG and Siderovski DP. A G protein gamma subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gbeta5 subunits. Proc Natl Acad Sci U S A 1998; 95: 13307-13312.
13. Martemyanov KA, Yoo PJ, Skiba NP and Arshavsky VY. R7BP, a novel neuronal protein interacting with RGS proteins of the R7 family. J Biol Chem 2005; 280: 5133-5136.
14. Chatterjee TK and Fisher RA. Mild heat and proteotoxic stress promote unique subcellular trafficking and nucleolar accumulation of RGS6 and other RGS proteins. Role of the RGS domain in stress-induced trafficking of RGS proteins. J Biol Chem 2003; 278: 30272-30282.
15. Maity B, Yang J, Huang J, Askeland RW, Bera S and Fisher RA. Regulator of G protein signaling 6 (RGS6) induces apoptosis via a mitochondrial-dependent pathway not involving its GTPase-activating protein activity. J Biol Chem 2011; 286: 1409-1419.
16. Maity B, Stewart A, O'Malley Y, Askeland RW, Sugg SL, Fisher RA. Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression. Carcinogenesis 2013; 34: 1747-1755.
17. Huang J, Stewart A, Maity B, Hagen J, Fagan RL, Yang J, Quelle DE, Brenner C and Fisher RA. RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis. Oncogene 2014; 33: 3604-11.
18. Yang J, Maity B, Huang J, Gao Z, Stewart A, Weiss RM, Anderson ME and Fisher RA. G-protein inactivator RGS6 mediates myocardial cell apoptosis and cardiomyopathy caused by doxorubicin. Cancer Res 2013; 73: 1662-1667.
19. Berman DM, Wang Y, Liu Z, Dong Q, Burke LA, Liotta LA, Fisher R and Wu X. A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer Res 2004; 64: 6820-6826.
20. Garcia-Carracedo D, Turk AT, Fine SA, Akhavan N, Tweel BC, Parsons R, Chabot JA, Allendorf JD, Genkinger JM, Remotti HE and Su GH. Loss of PTEN Expression Is Associated with Poor Prognosis in Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas. Clin Cancer Res 2013; 19: 6830-6841.
21. Shroff S, Overman MJ, Rashid A, Shroff RT, Wang H, Chatterjee D, Katz MH, Lee JE, Wolff RA, Abbruzzese JL, Fleming JB and Wang H. The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy. Arch Pathol Lab Med 2013; 137: 1619-1626.
22. Krasinskas AM, Chiosea SI, Pal T and Dacic S. KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas. Mod Pathol 2014; 27: 262-270.
23. Rice TW, Blackstone EH and Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 2010; 17: 1721-1724.
24. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
25. Guo S, Jing W, Hu X, Zhou X, Liu L, Zhu M, Yin F, Chen R, Zhao J and Guo Y. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients. Int J Cancer 2014; 134: 1369-1378.
26. Liang G, Bansal G, Xie Z and Druey KM. RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling. J Biol Chem 2009; 284: 21719-21727.
27. James MA, Lu Y, Liu Y, Vikis HG and You M. RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway. Cancer Res 2009; 69: 2108-2116.
28. Soini Y, Eskelinen M, Juvonen P, Kärjä V, Haapasaari KM, Saarela A and Karihtala P. Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma. Pathol Res Pract. Pathol Res Pract 2014; 210: 35-39.
29. Rhim AD and Stanger BZ. Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways. Prog Mol Biol Transl Sci 2010; 97: 41-78.
30. Mackenzie RP and McCollum AD. Novel agents for the treatment of adenocarcinoma of the pancreas. Expert Rev Anticancer Ther 2009; 9: 1473-1485.
31. Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, O'Reilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J and Tepper J. Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol 2009; 27: 5660-5669.
32. Kang MJ, Lee KB, Jang JY, Kwon W, Park JW, Chang YR and Kim SW. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN. Pancreas 2013; 42: 1267-1274.
33. Huang J, Yang J, Maity B, Mayuzumi D and Fisher RA. Regulator of G protein signaling 6 mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species-dependent mechanism. Cancer Res 2011; 71: 6310-6319.